sun pharmaceutical industries limited

sun pharmaceutical industries limited on Friday announced that one of its subsidiaries based in Romania has acquired the Uractiv portfolio from Fiterman Pharma in Romania.

Research is usually carried out by students pursuing PhDs or those who are studying in the last year of their master’s degree course. But MS University’s Faculty of Science is starting a new concept – curiosity laboratory – for grooming undergraduate students for research.

Global private equity firm Advent International will acquire a 50.1% equity stake in Hyderabad-based Suven Pharmaceuticals from the Jasti family for around Rs 6,313 crore (about $762 million). This would make it one of the largest deals in the pharma sector in recent years.

sun pharmaceutical industries limited is an Indian multinational pharmaceutical company that deals in pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and America. The company has its headquarters in Mumbai and produces specialty and generic products targeting a wide spectrum of chronic and acute treatments.

Call it the flu as well as the Covid effect. Antibiotic drug Augmentin has emerged as the largest selling brand in February, overtaking the established market leader for several years now — antidiabetic therapy Human Mixtard.

The BSE Sensex rallied 303 points to 60,261, while the Nifty50 climbed nearly 100 points to 17,957 on Friday.

Mumbai people suffering from cardiac problems can look forward to substantial savings in their healthcare budget several domestic companies including Glenmark and Lupin have launched generic versions of blockbuster cardiology drug Valsartan at a fraction of the price sold by the innovator Novartis others like Torrent Cipla and Sun Pharma are expected to follow suit.

Sun Pharmaceuticals reported a 5% increase in its consolidated net profit for the second quarter of FY 2024. The company's revenue also rose by 11.3% and its EBITDA came in at Rs 3,179 crore. Sun Pharma's India formulation sales increased by 11.1%, while US formulation sales increased by 4.2%. Sun Pharma also highlighted the positive phase-3 data for Nidlegy in patients with melanoma. The company's API business saw a 5.1% increase in external sales.

Leading drug makers Sun Pharma and Lupin are recalling products in the US market over manufacturing issues, as per the US Food and Drug Administration (FDA). Mumbai-based Sun Pharmaceutical Industries is recalling 96,192 bottles of Liothyronine Sodium Tablets in the US that are used to treat an underactive thyroid, according to the latest enforcement report issued by the American health regulator. The FDA stated that Mumbai-based Lupin is also recalling an unspecified number of penicillamine tablets in the US.

Call to save Vedanthangal Bird Sanctuary got louder with nature enthusiasts from Chennai starting a twitter campaign and online petitions on Sunday evening to condemn the government's recent proposal to commercialise 40% of the sanctuary.

The ACC has also named Dilip S Shanghvi as Member, Western Local Board of RBI.

The inaugural session of the seminar will have Dr Girish Kumar Agrawal from the Institute of Rural Management, Anand (IRMA) as speaker.

The founder of sun pharmaceutical industries limited, Dilip Shanghvi, on Saturday exuded confidence that the Indian pharma industry has the potential to discover at least a couple of new drugs in the next decade.

The 65th annual convocation of M S University will be held on Saturday afternoon.

Diabetes poses a significant threat to vision through Diabetic Retinopathy, affecting millions in India. Sun Pharma's #SeeBeyondSugar campaign highlights the critical need for regular eye check-ups alongside blood sugar management. Early detection and intervention are vital to prevent irreversible sight loss, urging a broader approach to diabetes care.

India is fast moving to become a $4 trillion economy. This is what Dilip Shanghvi, chairman and managing director of sun pharmaceutical industries limited said here while addressing the gathering of students, parents and officials of MS University during the 65th annual convocation ceremony.

Even as overall pharma exports showed a robust growth in 2020-21, Gujarat-based top pharma companies’ revenues from the US market declined in the fourth quarter ended March 31

Diabetic retinopathy, a serious complication of diabetes, damages the retina's blood vessels and often goes unnoticed in its early stages. Regular eye exams, even with controlled blood sugar, are crucial for early detection and preventing vision loss. Lifestyle changes and timely screenings are vital for maintaining eye health.

India today is home to over 100 million people living with diabetes and the number continues to rise rapidly. While much of the conversation around diabetes revolves around blood sugar control, one of its most serious and often overlooked complications is Diabetic Retinopathy - one of the leading causes of preventable blindness among adults.